Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

BWXT $104.74   $0.66 0.63% 
As of March 25, 2025. Minimum 20 minute delay.

News

BWXT Medical Enters into a New Long-Term Agreement with Boston Scientific

10 May 2021

(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company.

  BWXT Canada Ltd.  Corporate Announcement  Press Release

BWX Technologies Reports First Quarter 2021 Results and Commences New Multi-Year Guidance Framework

03 May 2021

  Investors  Media  Press Release

Press Contact:

John Dobken
+1 202.641.3013
jcdobken@bwxt.com

Archive

Tags

Show All453

Babcock and Wilcox Co. Archival82

BWXT Canada Ltd.36

Commercial Nuclear50

Commercial Nuclear Equipment15

Commercial Nuclear Services15

Contract Announcement132

Corporate Announcement122

Event9

Government Services43

Government Solutions41

Investors196

Media45

Nuclear Energy Canada1

Nuclear Fuel Services26

Nuclear Medicine7

Organizational Announcement81

Press Release452

Public Recognition8

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.